Improved Survival in 211 Patients With Stage IV Pulmonary and Gastroenteropancreatic mIBG Positive Neuroendocrine Tumors Treated With I-131 mIBG When Receiving Multiple Treatment Sessions or Demonstrating Imaging, Biochemical, or Symptomatic Response
Publication
, Conference
Borges-Neto, S; Thorpe, M; Kane, A; Wong, T; Morse, M
Published in: PANCREAS
March 1, 2019
Duke Scholars
Published In
PANCREAS
EISSN
1536-4828
ISSN
0885-3177
Publication Date
March 1, 2019
Volume
48
Issue
3
Start / End Page
429 / 429
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Borges-Neto, S., Thorpe, M., Kane, A., Wong, T., & Morse, M. (2019). Improved Survival in 211 Patients With Stage IV Pulmonary and Gastroenteropancreatic mIBG Positive Neuroendocrine Tumors Treated With I-131 mIBG When Receiving Multiple Treatment Sessions or Demonstrating Imaging, Biochemical, or Symptomatic Response. In PANCREAS (Vol. 48, pp. 429–429). LIPPINCOTT WILLIAMS & WILKINS.
Borges-Neto, Salvador, Matthew Thorpe, Ari Kane, Terrence Wong, and Michael Morse. “Improved Survival in 211 Patients With Stage IV Pulmonary and Gastroenteropancreatic mIBG Positive Neuroendocrine Tumors Treated With I-131 mIBG When Receiving Multiple Treatment Sessions or Demonstrating Imaging, Biochemical, or Symptomatic Response.” In PANCREAS, 48:429–429. LIPPINCOTT WILLIAMS & WILKINS, 2019.
Borges-Neto S, Thorpe M, Kane A, Wong T, Morse M. Improved Survival in 211 Patients With Stage IV Pulmonary and Gastroenteropancreatic mIBG Positive Neuroendocrine Tumors Treated With I-131 mIBG When Receiving Multiple Treatment Sessions or Demonstrating Imaging, Biochemical, or Symptomatic Response. In: PANCREAS. LIPPINCOTT WILLIAMS & WILKINS; 2019. p. 429–429.
Borges-Neto, Salvador, et al. “Improved Survival in 211 Patients With Stage IV Pulmonary and Gastroenteropancreatic mIBG Positive Neuroendocrine Tumors Treated With I-131 mIBG When Receiving Multiple Treatment Sessions or Demonstrating Imaging, Biochemical, or Symptomatic Response.” PANCREAS, vol. 48, no. 3, LIPPINCOTT WILLIAMS & WILKINS, 2019, pp. 429–429.
Borges-Neto S, Thorpe M, Kane A, Wong T, Morse M. Improved Survival in 211 Patients With Stage IV Pulmonary and Gastroenteropancreatic mIBG Positive Neuroendocrine Tumors Treated With I-131 mIBG When Receiving Multiple Treatment Sessions or Demonstrating Imaging, Biochemical, or Symptomatic Response. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS; 2019. p. 429–429.
Published In
PANCREAS
EISSN
1536-4828
ISSN
0885-3177
Publication Date
March 1, 2019
Volume
48
Issue
3
Start / End Page
429 / 429
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences